Myoepithelial cells lining milk ducts hold key to spread of DCIS

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 17 No 5
Volume 17
Issue 5

Researchers at Dana-Farber have found that normal myoepithelial cells, which form part of the lining of the milk ducts, suppress fibroblasts that promote tumor growth and invasion, but when certain genes in the myoepithelial layer become under- or overactive, the layer breaks down and disappears, enabling tumor cells to spread.

Researchers at Dana-Farber have found that normal myoepithelial cells, which form part of the lining of the milk ducts, suppress fibroblasts that promote tumor growth and invasion, but when certain genes in the myoepithelial layer become under- or overactive, the layer breaks down and disappears, enabling tumor cells to spread. The abnormal genes include TGF Beta, Hedgehog, and p63. The study was reported in the May 6 issue of Cancer Cell.

Recent Videos
9 Experts are featured in this series.
Vinay K. Puduvalli, MD, is featured in this series.
Genetic consultation and next-generation sequencing can also complement treatment strategies for patients with pancreatic cancer.
An advanced computation linguistics model that can detect pancreatic cysts can help patients prevent pancreatic tumors from forming.
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
Related Content